======= LMOD2 =======


== Gene Information ==
  * **<color #00a2e8>Official Symbol</color>**: LMOD2
  * **<color #00a2e8>Official Name</color>**: leiomodin 2
  * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A
  * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=442721|442721]]
  * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q6P5Q4|Q6P5Q4]]
  * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=LMOD2&organism=9606|BioGRID]]
  * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LMOD2|Open PubMed]]
  * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/608006|Open OMIM]]

== Function Summary ==
  * **<color #00a2e8>Entrez Summary</color>**: N/A
  * **<color #00a2e8>UniProt Summary</color>**:  Mediates nucleation of actin filaments and thereby promotes actin polymerization (PubMed:18403713, PubMed:26370058, PubMed:25250574, PubMed:26417072). Plays a role in the regulation of actin filament length (By similarity). Required for normal sarcomere organization in the heart, and for normal heart function (PubMed:18403713). {ECO:0000250|UniProtKB:Q3UHZ5, ECO:0000269|PubMed:18403713, ECO:0000269|PubMed:25250574, ECO:0000269|PubMed:26370058, ECO:0000269|PubMed:26417072}.

<button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button>
<button type='primary' size='sm' modal='GO_terms'>GO Terms</button>


<modal id='Pfam_Domains' size='lg' title='Pfam Domains'>
|Tropomodulin|
</modal>

<modal id='GO_terms' size='lg' title='GO Terms'>
|pointed-end actin filament capping|
|tropomyosin binding|
|striated muscle thin filament|
|actin monomer binding|
|M band|
|myofibril|
|actin filament polymerization|
|actin nucleation|
|actin filament capping|
|negative regulation of actin filament depolymerization|
|sarcomere organization|
|sarcomere|
|actin polymerization or depolymerization|
|regulation of actin filament depolymerization|
|negative regulation of actin filament polymerization|
|negative regulation of protein depolymerization|
|negative regulation of protein polymerization|
|myofibril assembly|
|negative regulation of protein complex disassembly|
|actin filament|
|regulation of protein depolymerization|
|protein polymerization|
|positive regulation of actin filament polymerization|
|cellular component assembly involved in morphogenesis|
|regulation of protein complex disassembly|
|actomyosin structure organization|
|positive regulation of protein polymerization|
|negative regulation of protein complex assembly|
|negative regulation of supramolecular fiber organization|
|striated muscle cell development|
|negative regulation of cytoskeleton organization|
|muscle cell development|
|regulation of actin filament polymerization|
|regulation of actin polymerization or depolymerization|
|regulation of actin filament length|
|positive regulation of supramolecular fiber organization|
|striated muscle cell differentiation|
|positive regulation of cytoskeleton organization|
|regulation of protein polymerization|
|actin filament organization|
|muscle cell differentiation|
|positive regulation of protein complex assembly|
|muscle contraction|
|regulation of actin filament organization|
|actin binding|
|muscle system process|
|regulation of actin cytoskeleton organization|
|regulation of supramolecular fiber organization|
|negative regulation of organelle organization|
|regulation of cellular component size|
|regulation of actin filament-based process|
|regulation of protein complex assembly|
|supramolecular fiber organization|
|muscle structure development|
|actin cytoskeleton organization|
|regulation of anatomical structure size|
|positive regulation of cellular component biogenesis|
|regulation of cytoskeleton organization|
|actin filament-based process|
|positive regulation of organelle organization|
|negative regulation of cellular component organization|
|organelle assembly|
|cellular component morphogenesis|
|cellular protein-containing complex assembly|
|anatomical structure formation involved in morphogenesis|
|regulation of cellular component biogenesis|
|cytoskeleton organization|
|positive regulation of cellular component organization|
|regulation of organelle organization|
|protein-containing complex assembly|
|cell development|
|protein-containing complex subunit organization|
|system process|
</modal>
\\

 === CRISPR Data ===
<button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button>
<button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button>
<button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button>

<modal id='Compound_Hit' size='lg' title='Compound Hit'>
^Screen^Score^
|[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.78|
</modal>

<modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'>
No correlation found to any other genes in chemogenomics.
</modal>

<modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'>
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
</modal>

== Essentiality in NALM6  ==
    * **<color #00a2e8>Essentiality Rank</color>**: 5724
    * **<color #00a2e8>Expression level (log2 read counts)</color>**: -2.17 
<button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button>
<modal id='Dist_expr' size='lg' title='LMOD2 Expression in NALM6 Cells: -2.17'>
{{:chemogenomics:nalm6 dist.png?nolink |}}
</modal>